This week’s SitRoom episode covered the COVID vaccine rollout. We were joined by special guests working on the front lines of manufacturing and / or distributing vaccines:
Scott Erwin is the Founder and CEO of Hirehand, a tech company helping fill shifts in dynamic staffing situations. Intelligent matching tech ideal for shifts that change and last minute drops. Hirehand is currently supporting Vaccine rollout in the UK, so Scott has some interesting insight into the logistical situation across the pond.
https://uk.linkedin.com/in/scottrerwin
Jump to Scott: https://youtu.be/dzL67bn8Upc?t=166
Matt Michelsen works as an emissary to global investors, corporate executives, and venture capitalists. Matt co-founded multiple companies and currently advises 8VC and Palantir. One biotech company Matt advises has been responsible for manufacturing a large number of COVID tests, and has been also been developing the vaccine on a mass scale.
https://www.gothams.com/team
Jump to Matt: https://youtu.be/dzL67bn8Upc?t=1159
Dr. Alexander J. Lazar is a leading pathologist in Texas (Pathologists diagnose and characterize diseases). He divides his time between clinical practice in cancer genomics / epigenomics and surgical pathology, research, teaching, and consulting. He operates extensively in the biotech and pharmaceutic space consulting for more than 30 companies across this entire ecosystem from Fortune 50 to garage start-up and serve on multiple permanent scientific advisory boards. He is working with one of Matt Michelsen's portfolio companies on COVID testing and vaccines (Curative).
https://www.linkedin.com/in/alexander...
Jump to Dr. Lazar: https://youtu.be/dzL67bn8Upc?t=2699
Jon Harrison is Chief Strategy Officer at COVAXX. COVAXX is developing the world’s first multitope peptide-based vaccine against SARS-CoV-2 to make immunity to COVID-19 accessible to all. COVAXX, through its sister companies in the United Biomedical Group, has already scaled production to 500 million doses/year, and through both internal expansion and a network of global partnerships we will increase that capacity to up to 1 billion doses/year by the end of 2021
https://www.covaxx.com/people
Jump to Jon: https://youtu.be/dzL67bn8Upc?t=2121